Researchers Present New Positive Interim Data on Appili Therapeutics’ ATI-1701 Biodefense Program at 2019 Chemical and Biological Defense Science & Technology Conference New data demonstrate durable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results